Back to Journals » Biologics: Targets and Therapy
![](https://www.dovepress.com/cr_data/cache/journal_image/8/cope/thumb_100_1000_100.jpg)
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (512)
- Volume 18, 2024 (16)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Journal Articles:
- 512 records -
STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression
Zhang WJ, Hu CL, Guo BL, Liang XP, Wang CY, Yang T
Biologics: Targets and Therapy 2024, 18:181-193
Published Date: 4 July 2024
Enzymatic Routes for Chiral Amine Synthesis: Protein Engineering and Process Optimization
Vikhrankar SS, Satbhai S, Kulkarni P, Ranbhor R, Ramakrishnan V, Kodgire P
Biologics: Targets and Therapy 2024, 18:165-179
Published Date: 25 June 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human-Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes [Response to Letter]
Zhou Y, Huang CLH, Zhang Y
Biologics: Targets and Therapy 2024, 18:163-164
Published Date: 25 June 2024
Osteoimmune Interaction and TH-1/TH-2 Ratio in Jawbone Marrow Defects: An Underestimated Association – Original Research
![](cr_data/cache/article_graphical_abstract/s448587/graphical_abstract.jpg)
Lechner J, von Baehr V, Notter F, Schick F
Biologics: Targets and Therapy 2024, 18:147-161
Published Date: 6 June 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes [Letter]
Wulandari M, Prihatono A, Rusdi AJ
Biologics: Targets and Therapy 2024, 18:145-146
Published Date: 5 June 2024
Response to “Lncrna GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC” [Letter]
Mahdi C, Wulandari M, Prisusanti RD
Biologics: Targets and Therapy 2024, 18:143-144
Published Date: 5 June 2024
LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC
Zhang J, You Q, Wang Y, Ji J
Biologics: Targets and Therapy 2024, 18:129-142
Published Date: 23 May 2024
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes
![](cr_data/cache/article_graphical_abstract/s448054/graphical_abstract.jpg)
Zhou Y, Zhou R, Huang W, Wang J, Jiang C, Li A, Huang CLH, Zhang Y
Biologics: Targets and Therapy 2024, 18:115-127
Published Date: 10 May 2024
Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula
Katsube S, Matsumoto S, Misawa M, Kakizawa N, Hashimoto R, Mizutani T, Matsumoto K, Yoshikawa S, Mashima H
Biologics: Targets and Therapy 2024, 18:107-113
Published Date: 6 May 2024
TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus
Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI
Biologics: Targets and Therapy 2024, 18:95-106
Published Date: 3 May 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Soberanis Pina P, Lheureux S
Biologics: Targets and Therapy 2024, 18:79-93
Published Date: 21 March 2024
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Lin W, Yan Y, Huang Q, Zheng D
Biologics: Targets and Therapy 2024, 18:61-78
Published Date: 31 January 2024
Advances with Platelet-Rich Plasma for Bone Healing
Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID
Biologics: Targets and Therapy 2024, 18:29-59
Published Date: 25 January 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing
Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC
Biologics: Targets and Therapy 2024, 18:21-28
Published Date: 18 January 2024
Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature
Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM
Biologics: Targets and Therapy 2024, 18:7-19
Published Date: 16 January 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis
Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H
Biologics: Targets and Therapy 2024, 18:1-6
Published Date: 12 January 2024
Hypoxia Inducible Factor-1α Through ROS/NLRP3 Pathway Regulates the Mechanism of Acute Ischemic Stroke Microglia Scorching Mechanism
Ma X, Jiao J, Aierken M, Sun H, Chen L
Biologics: Targets and Therapy 2023, 17:167-180
Published Date: 19 December 2023
The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice
Siderius M, Kieskamp SC, Wink F, Kroese FGM, Arends S, Spoorenberg A
Biologics: Targets and Therapy 2023, 17:161-166
Published Date: 14 December 2023
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study
Grazzini S, Conticini E, Falsetti P, D'Alessandro M, Sota J, Terribili R, Baldi C, Fabiani C, Bargagli E, Cantarini L, Frediani B
Biologics: Targets and Therapy 2023, 17:151-160
Published Date: 1 December 2023
Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value
Shehab-Eldeen S, Essa A, Arafat ES, Sleem AS, Alhosary AA, Darwish E, Essa A, Al-Omair OA, Al-Khoufi EA, Al Abdulqader AK, Nada A
Biologics: Targets and Therapy 2023, 17:137-149
Published Date: 13 October 2023
![Plain language summary](assets/img/article_icons/plain-language.png)
Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
Haddad A, Stein N, Lavi I, Shynkar L, Bergman I, Feldhamer I, Cohen AD, Saliba W, Zisman D
Biologics: Targets and Therapy 2023, 17:129-136
Published Date: 4 October 2023
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Zhang Z, Zhang R, Li D
Biologics: Targets and Therapy 2023, 17:113-128
Published Date: 21 September 2023
Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2023, 17:85-112
Published Date: 18 May 2023
New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
![](cr_data/cache/article_graphical_abstract/s405080/graphical_abstract.jpg)
Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A
Biologics: Targets and Therapy 2023, 17:69-83
Published Date: 15 May 2023
Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
Percik R, Oedegaard Smith C, Leibovici A, Shai A
Biologics: Targets and Therapy 2023, 17:61-67
Published Date: 3 May 2023
Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
Wu C, Zhang J, Zhao Y
Biologics: Targets and Therapy 2023, 17:57-60
Published Date: 20 April 2023
Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins
Kohram F, Deng Z, Zhang Y, Reza AA, Li E, Kolesnichenko OA, Shukla S, Ustiyan V, Gomez-Arroyo J, Acharya A, Shi D, Kalinichenko VV, Kenny AP
Biologics: Targets and Therapy 2023, 17:43-55
Published Date: 20 March 2023
Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
Panjaitan NSD, Handayani S, Dewi RM
Biologics: Targets and Therapy 2023, 17:41-42
Published Date: 20 March 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Why and How Should Ethiopia Establish a Stem Cell Transplant Service? A Review Article
Mekonnen S, Farris H
Biologics: Targets and Therapy 2023, 17:33-40
Published Date: 20 March 2023
Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
Essa A, Essa ES, El-deeb SM, Seleem HEM, Al Sahlawi M, Al-Omair OA, Shehab-Eldeen S
Biologics: Targets and Therapy 2023, 17:23-32
Published Date: 19 March 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment
Kurdi M, Mulla N, Katib Y, Alsinani T, Hakamy S, MJ Addas B, Malibary H, Halawa TF, S Farhan M, Faizo E, Baeesa S
Biologics: Targets and Therapy 2023, 17:15-22
Published Date: 5 February 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO
Biologics: Targets and Therapy 2023, 17:11-14
Published Date: 25 January 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH
Biologics: Targets and Therapy 2023, 17:1-9
Published Date: 18 January 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model
Santos-Moreno P, Sánchez-Vanegas G, Monterrosa-Blanco A, Rodríguez-Vargas GS, Rivero M, Rodriguez P, Calixto OJ, Rojas-Villarraga A, Castro CA
Biologics: Targets and Therapy 2022, 16:199-209
Published Date: 21 November 2022
TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
Calvo Alén J, Lavin-Gomez BA, Aurrecoechea E, Guerra Ruiz AR, Martínez Taboada V, Gómez Gerique J
Biologics: Targets and Therapy 2022, 16:187-197
Published Date: 17 October 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phage Therapy: A Different Approach to Fight Bacterial Infections
Hibstu Z, Belew H, Akelew Y, Mengist HM
Biologics: Targets and Therapy 2022, 16:173-186
Published Date: 6 October 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa
Batran RA, Elmoshneb M, Hussein AS, Hussien OM, Adel F, Elgarhy R, Morsi MI
Biologics: Targets and Therapy 2022, 16:161-171
Published Date: 6 October 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
van der Bent ML, Evers MM, Vallès A
Biologics: Targets and Therapy 2022, 16:141-160
Published Date: 30 September 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
Abdulla M, Mohammed N
Biologics: Targets and Therapy 2022, 16:129-140
Published Date: 12 September 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
Alorfi NM, Alourfi MM
Biologics: Targets and Therapy 2022, 16:119-127
Published Date: 5 August 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C
Biologics: Targets and Therapy 2022, 16:107-117
Published Date: 13 July 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2022, 16:89-105
Published Date: 8 July 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab
Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A
Biologics: Targets and Therapy 2022, 16:85-88
Published Date: 23 June 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Saleh A, Ansari U, Abughazaleh S, Glassner K, Abraham BP
Biologics: Targets and Therapy 2022, 16:67-83
Published Date: 17 June 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
Dipasquale V, Cucinotta U, Romano C
Biologics: Targets and Therapy 2022, 16:57-66
Published Date: 13 June 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
Mykoniatis I, Tsiakaras S, Samarinas M, Anastasiadis A, Symeonidis EN, Sountoulides P
Biologics: Targets and Therapy 2022, 16:47-55
Published Date: 20 May 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response
Dabi YT, Andualem H, Degechisa ST, Gizaw ST
Biologics: Targets and Therapy 2022, 16:35-45
Published Date: 9 May 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Progress in Biological Therapies for Adult-Onset Still’s Disease
Galozzi P, Bindoli S, Doria A, Sfriso P
Biologics: Targets and Therapy 2022, 16:21-34
Published Date: 21 April 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
Nishide M, Yagita M, Kumanogoh A
Biologics: Targets and Therapy 2022, 16:17-19
Published Date: 31 March 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
Temraz S, Nasr F, Kattan J, Abigerges D, Moukadem W, Farhat F, Maatouk L, Chahine G, Shamseddine A
Biologics: Targets and Therapy 2022, 16:7-15
Published Date: 21 February 2022